Literature DB >> 3521925

Tumor cell metastasis.

V P Terranova, S Hic, R M Diflorio, R M Lyall.   

Abstract

Local tissue invasion and the formation of metastatic lesions are characteristic properties of many malignant tumors. The formation of metastases is a complex process involving the passage of tumor cells from the site of the primary bulk tumor through successive connective tissue barriers, ultimately resulting in the growth of secondary tumor cell colonies in distinct target organ locations. At many stages in the metastatic process, tumor cells interact with multiple components of the extracellular matrix. Recently, the importance of basement membrane as a barrier to invasive cells has been recognized. In the course of the transition from in situ to invasive carcinoma, normal or dysplastic epithelial cells residing on a basement membrane are replaced by neoplastic cells which subsequently invade the basement membrane and enter the underlying stroma. Once in the stroma, tumor cells can then penetrate the walls of blood vessels or the lymphatic system and enter into the circulation. Circulating tumor cells next arrest in the lumina of small vessels, invade the vessel wall, and leave the circulation. These cells are now directly exposed to the extracellular matrix of a target organ where they may grow to form secondary tumors. Throughout the metastatic process tumor cells are thus in contact with, and are potentially responsive to, various components of the extracellular matrix. This review provides a survey of the recent advances in our understanding of the interactions of metastatic tumor cells with the extracellular matrix. Specifically, the role of basement membrane as a barrier to metastatic tumor cells is examined.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521925     DOI: 10.1016/s1040-8428(86)80022-1

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  3 in total

1.  Characterization of a connective tissue degrading metalloproteinase from human small cell lung cancer cells.

Authors:  S Zucker; T Turpeeniemi-Hujanen; J M Wieman; R M Lysik
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

2.  Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.

Authors:  Joshua J Timmons; Sean Cohessy; Eric T Wong
Journal:  J Vis Exp       Date:  2016-05-24       Impact factor: 1.355

Review 3.  Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.

Authors:  A Tachtsidis; L M McInnes; N Jacobsen; E W Thompson; C M Saunders
Journal:  Clin Exp Metastasis       Date:  2016-05-17       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.